South & Central America Poultry Vaccines Market Forecast to 2031

At 8.0% CAGR, South & Central America Poultry Vaccines Market is Projected to be Worth US$ 551.23 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the South & Central America poultry vaccines market was valued at US$ 298.35 million in 2023 and is anticipated to reach US$ 551.23 million by 2031, registering a CAGR of 8.0% from 2023 to 2031. Growing poultry industry and combination vaccines and rising prevalence of poultry diseases are among the critical factors attributed to drive the South & Central America poultry vaccines market growth.

According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world’s largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world’s poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.

On the contrary, vaccination failure and improper handling hamper the growth of South & Central America poultry vaccines market.

Based on type, the South & Central America poultry vaccines market is bifurcated into broiler and layer. The broiler segment held 62.2% market share in 2023, amassing US$ 185.71 million. It is projected to garner US$ 351.99 million by 2031 to register 8.3% CAGR during 2023-2031.

In terms of technology, the South & Central America poultry vaccines market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held 53.4% share of South & Central America poultry vaccines market in 2023, amassing US$ 159.32 million. It is projected to garner US$ 298.32 million by 2031 to register 8.2% CAGR during 2023-2031.

By dosage form, the South & Central America poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held 51.9% share of South & Central America poultry vaccines market in 2023, amassing US$ 154.97 million. It is projected to garner US$ 296.37 million by 2031 to expand at 8.4% CAGR from 2023 to 2031.

Based on type of disease, the South & Central America poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek’s disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The Newcastle disease segment held 28.6% share of South & Central America poultry vaccines market in 2023, amassing US$ 85.36 million. It is predicted to garner US$ 166.08 million by 2031 to expand at 8.7% CAGR between 2023 and 2031.

By route of administration, the South & Central America poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held 40.5% share of South & Central America poultry vaccines market in 2023, amassing US$ 120.70 million. It is estimated to garner US$ 232.69 million by 2031 to expand at 8.6% CAGR during 2023-2031.

In terms of end user, the South & Central America poultry vaccines market is categorized into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held 53.7% share of South & Central America hearing aids market in 2023, amassing US$ 160.21 million. It is projected to garner US$ 307.06 million by 2031 to expand at 8.5% CAGR from 2023 to 2031.

Based on country, the South & Central America poultry vaccines market is categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 70.3% share of South & Central America poultry vaccines market in 2023. It was assessed at US$ 209.83 million in 2023 and is likely to hit US$ 394.46 million by 2031, registering a CAGR of 8.2% during 2023-2031.

Key players operating in the South & Central America poultry vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB, among others.

In January 2020, Boehringer Ingelheim has launched VAXXITEK HVT+IBD+ND. The vaccines provides a strong immune foundation and optimized protection against Marek’s Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America poultry vaccines market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America poultry vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America poultry vaccines market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
4. Poultry Vaccines Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Poultry Diseases
4.1.2 Growing Poultry Industry
4.2 Market Restraints
4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:
5. South & Central America Poultry Vaccines Market Analysis
5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031
6. South & Central America Poultry Vaccines Market Analysis – by Type
6.1 Overview
6.2 Broiler
6.2.1 Overview
6.2.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
6.3.1 Overview
6.3.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7. South & Central America Poultry Vaccines Market Analysis – by Technology
7.1 Overview
7.2 Live Attenuated Vaccines
7.2.1 Overview
7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
7.3.1 Overview
7.3.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
7.4.1 Overview
7.4.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Poultry Vaccines Market Analysis – by Dosage Form
8.1 Overview
8.2 Liquid Vaccines
8.2.1 Overview
8.2.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
8.3.1 Overview
8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
8.4.1 Overview
8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Poultry Vaccines Market Analysis – by Disease
9.1 Overview
9.2 Avian Influenza
9.2.1 Overview
9.2.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Avian Salmonellosis
9.3.1 Overview
9.3.2 Avian Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Marek’s Disease
9.4.1 Overview
9.4.2 Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
9.5.1 Overview
9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
9.6.1 Overview
9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
9.7.1 Overview
9.7.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Poultry Vaccines Market Analysis – by Route of Administration
10.1 Overview
10.2 Drinking Water (D/W)
10.2.1 Overview
10.2.2 Drinking Water (D/W): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
10.3.1 Overview
10.3.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
10.4.1 Overview
10.4.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11. South & Central America Poultry Vaccines Market Analysis – by End User
11.1 Overview
11.2 Poultry Farms
11.2.1 Overview
11.2.2 Poultry Farms: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
11.3.1 Overview
11.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers & Clinics
11.4.1 Overview
11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12. South & Central America Poultry Vaccines Market – Country Analysis
12.1 South & Central America Market Overview
12.1.1 Poultry Vaccines Market Breakdown by Countries
12.1.2 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
12.1.2.1 Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.2.1.1 Overview
12.1.2.1.2 Brazil: Poultry Vaccines Market Breakdown by Type
12.1.2.1.3 Brazil: Poultry Vaccines Market Breakdown by Technology
12.1.2.1.4 Brazil: Poultry Vaccines Market Breakdown by Dosage Form
12.1.2.1.5 Brazil: Poultry Vaccines Market Breakdown by Disease
12.1.2.1.6 Brazil: Poultry Vaccines Market Breakdown by Route of Administration
12.1.2.1.7 Brazil: Poultry Vaccines Market Breakdown by End User
12.1.2.2 Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.2.2.1 Overview
12.1.2.2.2 Argentina: Poultry Vaccines Market Breakdown by Type
12.1.2.2.3 Argentina: Poultry Vaccines Market Breakdown by Technology
12.1.2.2.4 Argentina: Poultry Vaccines Market Breakdown by Dosage Form
12.1.2.2.5 Argentina: Poultry Vaccines Market Breakdown by Disease
12.1.2.2.6 Argentina: Poultry Vaccines Market Breakdown by Route of Administration
12.1.2.2.7 Argentina: Poultry Vaccines Market Breakdown by End User
12.1.2.3 Rest of South & Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.2.3.1 Overview
12.1.2.3.2 Rest of South & Central America: Poultry Vaccines Market Breakdown by Type
12.1.2.3.3 Rest of South & Central America: Poultry Vaccines Market Breakdown by Technology
12.1.2.3.4 Rest of South & Central America: Poultry Vaccines Market Breakdown by Dosage Form
12.1.2.3.5 Rest of South & Central America: Poultry Vaccines Market Breakdown by Disease
12.1.2.3.6 Rest of South & Central America: Poultry Vaccines Market Breakdown by Route of Administration
12.1.2.3.7 Rest of South & Central America: Poultry Vaccines Market Breakdown by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Global Poultry Vaccines Market
13.3 Organic Developments
13.3.1 Overview
13.1 Inorganic Developments
13.1.1 Overview
14. Company Profiles
14.1 Boehringer Ingelheim International GmbH
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Zoetis Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Phibro Animal Health Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Dechra Pharmaceuticals PLC
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Elanco Animal Health Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Ceva
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Vaccinova AB
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About The Research Team
15.2 Glossary of Terms

LIST OF TABLES

Table 1. South & Central America Poultry Vaccines Market Segmentation
Table 2. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 3. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 5. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 6. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 7. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 8. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 9. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 10. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 11. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 12. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 13. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 14. Rest of South & Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 15. Rest of South & Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 16. Rest of South & Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 17. Rest of South & Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 18. Rest of South & Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 19. Rest of South & Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, Poultry Vaccines Market

LIST OF FIGURES

Figure 1. South & Central America Poultry Vaccines Market Segmentation, by Country
Figure 2. Poultry Vaccines Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031
Figure 5. Poultry Vaccines Market Share (%) – by Type, 2023 and 2031
Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 8. Poultry Vaccines Market Share (%) – by Technology, 2023 and 2031
Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 12. Poultry Vaccines Market Share (%) – by Dosage Form, 2023 and 2031
Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 16. Poultry Vaccines Market Share (%) – by Disease, 2023 and 2031
Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 19. Marek’s Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 24. Poultry Vaccines Market Share (%) – by Route of Administration, 2023 and 2031
Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 29. Poultry Vaccines Market Share (%) – by End User, 2023 and 2031
Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 32. Poultry Vaccination Centers & Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 33. South & Central America: Poultry Vaccines Market by Key Countries – Revenue 2023 (US$ Million)
Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 35. Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 36. Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 37. Rest of South & Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 38. Growth Strategies in the Poultry Vaccines Market